Elevance Health SG&A Expenses 2010-2024 | ELV
Elevance Health annual/quarterly sg&a expenses history and growth rate from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
- Elevance Health sg&a expenses for the quarter ending March 31, 2024 were $M, a NAN% increase year-over-year.
- Elevance Health sg&a expenses for the twelve months ending March 31, 2024 were $0M, a NAN% increase year-over-year.
- Elevance Health annual sg&a expenses for 2023 were $0B, a NAN% decline from 2022.
- Elevance Health annual sg&a expenses for 2022 were $0B, a NAN% decline from 2021.
- Elevance Health annual sg&a expenses for 2021 were $0B, a 100% decline from 2020.
| Elevance Health Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2023 | $ |
| 2022 | $ |
| 2021 | $ |
| 2020 | $17,450 |
| 2019 | $13,364 |
| 2018 | $14,020 |
| 2017 | $12,650 |
| 2016 | $12,559 |
| 2015 | $12,535 |
| 2014 | $11,748 |
| 2013 | $9,953 |
| 2012 | $8,681 |
| 2011 | $8,436 |
| 2010 | $8,733 |
| 2009 | $9,019 |
| Elevance Health Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | $3,946 |
| 2021-06-30 | $3,821 |
| 2021-03-31 | $3,925 |
| 2020-12-31 | $4,318 |
| 2020-09-30 | $5,305 |
| 2020-06-30 | $4,046 |
| 2020-03-31 | $3,781 |
| 2019-12-31 | $3,502 |
| 2019-09-30 | $3,418 |
| 2019-06-30 | $3,278 |
| 2019-03-31 | $3,166 |
| 2018-12-31 | $3,618 |
| 2018-09-30 | $3,546 |
| 2018-06-30 | $3,428 |
| 2018-03-31 | $3,428 |
| 2017-12-31 | $3,394 |
| 2017-09-30 | $3,011 |
| 2017-06-30 | $3,054 |
| 2017-03-31 | $3,191 |
| 2016-12-31 | $3,265 |
| 2016-09-30 | $3,125 |
| 2016-06-30 | $2,969 |
| 2016-03-31 | $3,200 |
| 2015-12-31 | $3,268 |
| 2015-09-30 | $3,080 |
| 2015-06-30 | $3,041 |
| 2015-03-31 | $3,145 |
| 2014-12-31 | $3,033 |
| 2014-09-30 | $2,968 |
| 2014-06-30 | $2,886 |
| 2014-03-31 | $2,862 |
| 2013-12-31 | $2,646 |
| 2013-09-30 | $2,543 |
| 2013-06-30 | $2,436 |
| 2013-03-31 | $2,329 |
| 2012-12-31 | $2,354 |
| 2012-09-30 | $2,079 |
| 2012-06-30 | $2,082 |
| 2012-03-31 | $2,166 |
| 2011-12-31 | $2,228 |
| 2011-09-30 | $2,120 |
| 2011-06-30 | $2,011 |
| 2011-03-31 | $2,077 |
| 2010-12-31 | $2,341 |
| 2010-09-30 | $2,063 |
| 2010-06-30 | $2,155 |
| 2010-03-31 | $2,174 |
| 2009-12-31 | $2,324 |
| 2009-09-30 | $2,260 |
| 2009-06-30 | $2,206 |
| 2009-03-31 | $2,229 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $117.915B | $171.340B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora (COR) | United States | $43.985B | 17.15 |
| ICON (ICLR) | Ireland | $26.639B | 25.15 |
| DiDi Global (DIDIY) | China | $22.358B | 0.00 |
| Avantor (AVTR) | United States | $16.031B | 23.60 |
| CochLear (CHEOY) | Australia | $13.625B | 0.00 |
| Natera (NTRA) | United States | $13.523B | 0.00 |
| Revvity (RVTY) | United States | $13.368B | 23.45 |
| Viatris (VTRS) | United States | $12.478B | 3.73 |
| Medpace Holdings (MEDP) | United States | $11.950B | 39.32 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.358B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.803B | 20.68 |
| Solventum (SOLV) | United States | $10.078B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $7.710B | 0.00 |
| HealthEquity (HQY) | United States | $6.884B | 50.72 |
| Bausch + Lomb (BLCO) | Canada | $5.410B | 21.68 |
| Organon (OGN) | United States | $5.385B | 5.11 |
| Doximity (DOCS) | United States | $5.177B | 36.04 |
| PACS (PACS) | United States | $4.499B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.467B | 31.72 |
| Life Times (LTH) | United States | $3.279B | 34.35 |
| Sotera Health (SHC) | United States | $3.139B | 15.40 |
| GoodRx Holdings (GDRX) | United States | $2.837B | 108.00 |
| Agilon Health (AGL) | United States | $2.566B | 0.00 |
| Progyny (PGNY) | United States | $2.535B | 43.64 |
| NovoCure (NVCR) | Jersey | $2.397B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.064B | 8.18 |
| Premier (PINC) | United States | $1.985B | 8.49 |
| BrightSpring Health Services (BTSG) | United States | $1.962B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.915B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.507B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.420B | 0.00 | |
| Embecta (EMBC) | United States | $0.717B | 4.87 |
| CareDx (CDNA) | United States | $0.704B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.645B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.619B | 6.57 |
| InnovAge Holding (INNV) | United States | $0.589B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 15.27 |
| GeneDx Holdings (WGS) | United States | $0.533B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.507B | 0.00 |
| Enhabit (EHAB) | United States | $0.461B | 46.00 |
| ModivCare (MODV) | United States | $0.403B | 7.54 |
| Sonida Senior Living (SNDA) | United States | $0.383B | 0.00 |
| LifeMD (LFMD) | United States | $0.359B | 0.00 |
| MultiPlan (MPLN) | United States | $0.348B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.324B | 0.00 |
| Sharecare (SHCR) | United States | $0.306B | 0.00 |
| DocGo (DCGO) | United States | $0.300B | 16.39 |
| Beauty Health (SKIN) | United States | $0.270B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.223B | 0.00 |
| Biodesix (BDSX) | United States | $0.155B | 0.00 |
| So-Young (SY) | China | $0.104B | 52.50 |
| Pono Capital Two (PTWO) | United States | $0.071B | 0.00 |
| NeueHealth (NEUE) | United States | $0.050B | 6.71 |
| IceCure Medical (ICCM) | Israel | $0.048B | 0.00 |
| Oncology Institute (TOI) | United States | $0.035B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.033B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.028B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.027B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.026B | 0.00 |
| OncoCyte (OCX) | United States | $0.022B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| DermTech (DMTK) | United States | $0.011B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| OpGen (OPGN) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |